Abbott Laboratories logo
Abbott Laboratories (ABT)
Compare

Abbott Laboratories (ABT) EV/FCF Ratio: 24.92x

Is Abbott Laboratories’s EV/FCF ratio high or low?

Abbott Laboratories's EV/FCF ratio of 24.92x is 20% below its 5-year average of 31.02x, near the low end of its 5-year range (20.72x–46.60x).

As of Friday, June 12, 2026. 19.51% below its 12-month average of 30.96x.

ABT EV/FCF Ratio Chart

ABT EV/FCF Ratio
24.92x-31.74% 1Y
Zoom

ABT Average EV/FCF Ratio Chart

ABT Current vs Average EV/FCF Ratio Chart

ABT EV/FCF Ratio Metrics

EV/FCF RATIO

24.92x

EV/FCF RATIO AVG TTM

30.96x

EV/FCF RATIO AVG 3Y

34.90x

EV/FCF RATIO AVG 5Y

31.02x

EV/FCF RATIO AVG 10Y

33.44x

EV/FCF RATIO AVG 15Y

28.99x

EV/FCF RATIO AVG 20Y

24.24x

CURRENT VS TTM AVG

-19.51%

CURRENT VS 3Y AVG

-28.59%

CURRENT VS 5Y AVG

-19.67%

CURRENT VS 10Y AVG

-25.48%

CURRENT VS 15Y AVG

-14.05%

CURRENT VS 20Y AVG

+2.81%

ABT Competitors' EV/FCF Ratio

NAMEMARKET CAPEV/FCF RATIOTTM3Y5Y
Abbott Laboratories (ABT)$156.15B24.92x30.96x34.90x31.02x
Gilead Sciences, Inc. (GILD)$156.28B16.85x18.52x16.04x14.51x
Pfizer Inc. (PFE)$149.18B22.43x19.77x27.32x21.37x
Intuitive Surgical, Inc. (ISRG)$146.23B51.70x79.55x160.31x125.13x
Thermo Fisher Scientific Inc. (TMO)$176.77B32.21x35.74x34.61x34.76x
CVS Health Corporation (CVS)$129.25B26.69x27.82x26.94x21.13x
Danaher Corporation (DHR)$128.27B26.72x31.95x32.29x30.49x
Amgen Inc. (AMGN)$191.09B27.67x22.37x24.94x22.50x
Bristol-Myers Squibb Company (BMY)$116.19B12.69x10.44x11.39x12.31x
Vertex Pharmaceuticals Incorporated (VRTX)$112.95B29.80x32.26x28.31x25.04x

Cash Flow Valuation Comparison

EV/FCF

24.9x

P/FCF

21.2x

FCF Yield

4.71%

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

  • EV/FCF accounts for debt and cash through enterprise value
  • P/FCF only considers equity value
  • EV/FCF can be compared across companies with different debt levels
  • Both measure how the market values cash generation

Abbott Laboratories EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Abbott Laboratories EV/FCF Ratio FAQ

What is the EV/FCF ratio for Abbott Laboratories (ABT)?
The EV/FCF ratio for ABT stock is 24.92x.
Is Abbott Laboratories's EV/FCF ratio high or low?
Abbott Laboratories's EV/FCF ratio of 24.92x is 20% below its 5-year average of 31.02x, near the low end of its 5-year range (20.72x–46.60x).
What is the TTM average EV/FCF ratio for Abbott Laboratories (ABT)?
The TTM average EV/FCF ratio for ABT stock is 30.96x.
What is the 3Y average EV/FCF ratio for Abbott Laboratories (ABT)?
The 3Y average EV/FCF ratio for ABT stock is 34.90x.
What is the 5Y average EV/FCF ratio for Abbott Laboratories (ABT)?
The 5Y average EV/FCF ratio for ABT stock is 31.02x.
What is the 10Y average EV/FCF ratio for Abbott Laboratories (ABT)?
The 10Y average EV/FCF ratio for ABT stock is 33.44x.
What is the 15Y average EV/FCF ratio for Abbott Laboratories (ABT)?
The 15Y average EV/FCF ratio for ABT stock is 28.99x.
What is the 20Y average EV/FCF ratio for Abbott Laboratories (ABT)?
The 20Y average EV/FCF ratio for ABT stock is 24.24x.

Abbott Laboratories EV/FCF Ratio History

DATEEV/FCF RATIO
2026-06-1124.92x
2026-06-1024.81x
2026-06-0925.30x
2026-06-0825.12x
2026-06-0525.26x
2026-06-0425.19x
2026-06-0324.29x
2026-06-0224.29x
2026-06-0124.48x
2026-05-2923.96x
2026-05-2824.13x
2026-05-2723.98x
2026-05-2624.21x
2026-05-2224.39x
2026-05-2124.48x
2026-05-2024.62x
2026-05-1924.72x
2026-05-1824.51x
2026-05-1523.69x
2026-05-1423.80x
2026-05-1323.54x
2026-05-1223.67x
2026-05-1123.24x
2026-05-0823.66x
2026-05-0724.30x
2026-05-0624.13x
2026-05-0524.33x
2026-05-0424.42x
2026-05-0124.88x
2026-04-3025.19x
2026-04-2925.32x
2026-04-2823.06x
2026-04-2722.81x
2026-04-2422.41x
2026-04-2322.73x
2026-04-2222.55x
2026-04-2122.79x
2026-04-2023.56x
2026-04-1723.76x
2026-04-1623.44x
2026-04-1524.88x
2026-04-1424.76x
2026-04-1324.67x
2026-04-1024.58x
2026-04-0925.15x
2026-04-0825.35x
2026-04-0724.94x
2026-04-0625.05x
2026-04-0225.19x
2026-04-0125.07x
2026-03-3125.14x
2026-03-3024.95x
2026-03-2725.45x
2026-03-2625.59x
2026-03-2525.65x
2026-03-2425.47x
2026-03-2325.65x
2026-03-2025.80x
2026-03-1926.21x
2026-03-1826.51x
2026-03-1727.04x
2026-03-1626.86x
2026-03-1326.41x
2026-03-1226.43x
2026-03-1126.93x
2026-03-1027.00x
2026-03-0927.50x
2026-03-0626.77x
2026-03-0527.12x
2026-03-0427.60x
2026-03-0327.72x
2026-03-0227.84x
2026-02-2728.37x
2026-02-2628.35x
2026-02-2528.00x
2026-02-2427.95x
2026-02-2328.12x
2026-02-2027.39x
2026-02-1929.15x
2026-02-1829.43x
2026-02-1729.17x
2026-02-1329.28x
2026-02-1228.97x
2026-02-1129.51x
2026-02-1029.18x
2026-02-0928.87x
2026-02-0628.81x
2026-02-0528.37x
2026-02-0428.14x
2026-02-0328.35x
2026-02-0228.45x
2026-01-3028.42x
2026-01-2927.61x
2026-01-2827.60x
2026-01-2728.16x
2026-01-2628.29x
2026-01-2327.95x
2026-01-2228.25x
2026-01-2131.31x
2026-01-2031.42x
2026-01-1631.57x
2026-01-1532.02x
2026-01-1432.39x
2026-01-1332.21x
2026-01-1232.30x
2026-01-0932.62x
2026-01-0832.69x
2026-01-0732.91x
2026-01-0633.10x
2026-01-0532.76x
2026-01-0232.19x
2025-12-3132.47x
2025-12-3032.59x
2025-12-2932.28x
2025-12-2632.35x
2025-12-2432.34x
2025-12-2332.28x
2025-12-2232.45x
2025-12-1932.51x
2025-12-1832.42x
2025-12-1732.82x
2025-12-1632.86x
2025-12-1533.27x
2025-12-1232.51x
2025-12-1131.96x
2025-12-1031.77x
2025-12-0931.44x
2025-12-0831.66x
2025-12-0532.41x
2025-12-0432.49x
2025-12-0332.47x
2025-12-0232.73x
2025-12-0133.15x
2025-11-2833.38x
2025-11-2633.29x
2025-11-2533.16x
2025-11-2432.95x
2025-11-2133.18x
2025-11-2032.13x
2025-11-1932.68x
2025-11-1833.66x
2025-11-1733.66x
2025-11-1433.81x
2025-11-1333.47x
2025-11-1233.36x
2025-11-1132.90x
2025-11-1032.62x
2025-11-0732.74x
2025-11-0632.38x
2025-11-0532.28x
2025-11-0432.59x
2025-11-0332.10x
2025-10-3132.04x
2025-10-3032.31x
2025-10-2932.25x
2025-10-2833.68x
2025-10-2733.83x
2025-10-2433.74x
2025-10-2333.61x
2025-10-2234.03x
2025-10-2133.92x
2025-10-2034.43x
2025-10-1734.18x
2025-10-1633.94x
2025-10-1534.41x
2025-10-1435.40x
2025-10-1334.91x
2025-10-1035.22x
2025-10-0935.41x
2025-10-0835.66x
2025-10-0735.34x
2025-10-0635.52x
2025-10-0335.74x
2025-10-0235.33x
2025-10-0135.45x
2025-09-3035.57x
2025-09-2935.36x
2025-09-2635.47x
2025-09-2535.41x
2025-09-2435.56x
2025-09-2336.08x
2025-09-2236.27x
2025-09-1936.12x
2025-09-1835.74x
2025-09-1735.63x
2025-09-1635.27x
2025-09-1534.90x
2025-09-1235.52x
2025-09-1135.24x
2025-09-1034.39x
2025-09-0935.06x
2025-09-0835.12x
2025-09-0535.32x
2025-09-0435.28x
2025-09-0335.12x
2025-09-0234.93x
2025-08-2935.24x
2025-08-2834.91x
2025-08-2734.93x
2025-08-2634.97x
2025-08-2535.04x
2025-08-2235.23x
2025-08-2135.07x
2025-08-2035.19x
2025-08-1934.88x
2025-08-1834.63x
2025-08-1535.01x
2025-08-1434.37x
2025-08-1334.40x
2025-08-1234.82x
2025-08-1134.91x
2025-08-0835.66x
2025-08-0735.09x
2025-08-0634.80x
2025-08-0534.73x
2025-08-0434.54x
2025-08-0133.86x
2025-07-3133.57x
2025-07-3034.18x
2025-07-2934.61x
2025-07-2834.17x
2025-07-2534.22x
2025-07-2433.98x
2025-07-2334.03x
2025-07-2234.01x
2025-07-2133.66x
2025-07-1833.47x
2025-07-1732.64x
2025-07-1635.58x
2025-07-1535.52x
2025-07-1435.66x
2025-07-1135.66x
2025-07-1036.07x
2025-07-0935.97x
2025-07-0836.01x
2025-07-0736.10x
2025-07-0336.29x
2025-07-0236.21x
2025-07-0136.77x
2025-06-3036.71x
2025-06-2736.28x
2025-06-2636.09x
2025-06-2537.07x
2025-06-2437.25x
2025-06-2335.98x
2025-06-2035.91x
2025-06-1835.76x
2025-06-1735.73x
2025-06-1636.18x
2025-06-1336.60x
2025-06-1236.82x
2025-06-1136.51x
2025-06-1036.21x
2025-06-0936.02x
2025-06-0636.07x
2025-06-0536.16x
2025-06-0435.91x
2025-06-0336.10x
2025-06-0236.07x
2025-05-3036.07x

Showing the most recent 260 of 5,032 data points. The chart above shows the full history.

About Abbott Laboratories

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

Abbott Park, IL
114,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Robert Ford